烧伤后瘢痕颜色如何评估——Mexameter®与主观瘢痕评估(POSAS/VSS)的临床比较
这项前瞻性单中心研究纳入60例曾接受皮肤移植的Ⅲ度烧伤患者共120处瘢痕区域,由同一评估者用Mexameter® MX 18、OSAS和VSS评估颜色、色素沉着与血管化,患者完成PSAS。结果显示瘢痕区与健康皮肤黑色素指数差异较小(12,p<0.05),红斑差异均值为84(p<0.001);Mexameter®与OSAS相关性中等,27%的瘢痕被观察者误判为色素沉着过度,21%误判为血管化过度。作者认为Mexameter®可克服颜色评估的主观性,并提出了新的Mexameter®瘢痕量表。
要点
- OSAS评估中61%的瘢痕为色素沉着过度、19%为色素减退、19%为混合型。
- 65%的瘢痕被评估为高度血管化。
- Mexameter®红斑与OSAS血管化相关性r=0.33(p<0.05),黑色素与色素沉着相关性r=0.28(p<0.05)。
核心结论
- 作者认为Mexameter®可克服评估者与患者对瘢痕颜色评估的主观性,但主观评估工具仍能确保精确区分。
- 作者提出了新的Mexameter®瘢痕量表。
- 作者认为有必要进一步研究大量客观设备,并开发整合客观与主观设备的瘢痕评估面板,以减少偏倚、提高可靠性。
研究设计与样本
- 前瞻性单中心研究,纳入60例1975年至2018年间接受皮肤移植、总面积烧伤(TBSA)>2%的Ⅲ度烧伤患者,共检查120处瘢痕区域。
- 每例评估两处瘢痕区域并与一处健康皮肤区域比较颜色、色素沉着和血管化,由同一评估者使用Mexameter® MX 18、OSAS和VSS评估,患者完成PSAS。
主要发现
- 60例患者平均TBSA为24.3%。
- OSAS评估中61%的瘢痕为色素沉着过度、19%为色素减退、19%为混合型;65%的瘢痕被评估为高度血管化。
- Mexameter®测得瘢痕区与健康皮肤区黑色素指数差异较小,为12(p<0.05);红斑平均差异为84(p<0.001)。
- Mexameter®红斑与OSAS血管化类别相关性中等(r=0.33,p<0.05),黑色素与OSAS色素沉着参数相关性中等(r=0.28,p<0.05)。
- 与OSAS问卷比较,27%的瘢痕被观察者误判为色素沉着过度、21%误判为血管化过度,而设备测量值较低。
关键数值与推荐
- Mexameter®黑色素指数:瘢痕区与健康皮肤区差异为12(p<0.05)。
- Mexameter®红斑:瘢痕区与健康皮肤区平均差异为84(p<0.001)。
- Mexameter®红斑与OSAS血管化:r=0.33(p<0.05)。
- Mexameter®黑色素与OSAS色素沉着:r=0.28(p<0.05)。
- 观察者误判:27%的瘢痕被误判为色素沉着过度,21%被误判为血管化过度。
临床怎么用
- 作者认为Mexameter®可克服评估者与患者对瘢痕颜色评估的主观性。
- 作者认为主观评估工具仍能确保精确区分。
- 作者提出了新的Mexameter®瘢痕量表。
- 作者认为有必要进一步研究大量客观设备,并开发整合客观与主观设备的瘢痕评估面板。
局限性
- 作者认为有必要进一步研究大量客观设备并开发整合客观与主观设备的瘢痕评估面板,以进一步减少偏倚、提高可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Scarring after burn injuries remains one of the major challenges in burn medicine and is the subject of current research. Accurate and high-quality assessment of scars is needed to enable exact outcome evaluation of different treatments. Our aim was to evaluate the most common subjective scar evaluation scores-the POSAS (Patient and Observer Scar Assessment Scale) and VSS (Vancouver Scar Scale)-in comparison with the objective device Mexameter® for colour evaluation. METHODS: A prospective monocentre study was performed, which included 120 examined scar areas of 60 patients with third degree burns who had received skin grafts between 1975 and 2018 with a total burned surface area (TBSA) > 2%. Two different scar areas in comparison with one healthy skin area concerning 'colour', 'pigmentation', and 'vascularization' were evaluated by the Mexameter® MX 18, the OSAS, and the VSS by the same examiner, as well as the PSAS by the patient. RESULTS: The mean TBSA of the 60 patients was 24.3%. In the OSAS, 61% of the scars were evaluated as 'hyper-', 19% as 'hypo-', and 19% as 'mix-pigmented'. Furthermore, 65% of the scars were estimated as highly vascularized. In the Mexameter®, the melanin index values of the scar areas compared to the healthy skin areas showed a small difference of 12 (p < 0.05). The mean difference of erythema between the scar and the healthy skin areas was 84 (p < 0.001). For the Mexameter®, moderate correlations were found when comparing 'erythema' with the OSAS category 'vascularization' (r = 0.33, p < 0.05) and 'melanin' with the OSAS parameter 'pigmentation' (r = 0.28, p < 0.05). When comparing the Mexameter® measurements to the OSAS questionnaire, 27% of the scars were wrongly evaluated as 'hyperpigmented' by the observer and 21% as 'hypervascularized', while showing low measurements in the device. Additionally, a novel Mexameter® ordinal scare scale was calculated. CONCLUSION: In this study, we were able to show on a relatively large patient population that with the Mexameter®, the subjectivity of the scar colour assessment by examiner/patient can be overcome, but precise differentiation can still be ensured with subjective evaluation tools. We further introduced a novel Mexameter® Scar Scale. It is necessary to further investigate the vast range of objective devices and develop scar panels for with an incorporation of objective and subjective devices to further improve reliability with reduced bias in terms of scar assessment.
引用
- Bagheri M, von Kohout M, Fuchs PC, et al. How to evaluate scar colour after burn injuries - A clinical comparison of the Mexameter® and the subjective scar assessment (POSAS/VSS). Burns. 2023. PMID: 38097444. doi:10.1016/j.burns.2023.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。